Our Mission
To advance precision immunotherapies that empower the immune system and improve long-term cancer outcomes.
About Us
We combine science, ethics, and patient-centered research
At Celyad Oncology USA, our mission is to develop next-generation CAR T-cell therapies with the potential to transform outcomes for patients with blood cancers and solid tumors. We invest in advanced discovery, clinical development, and collaborative partnerships to bring new opportunities to cancer care.
Research Focus
Combining innovative cell engineering with translational science to accelerate therapy development.
Patient Commitment
Supporting rigorous clinical trials with patient safety, transparency, and ethical oversight at the core.